You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

CLINICAL TRIALS PROFILE FOR SOTRADECOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SOTRADECOL

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00442364 ↗	Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt	Completed	Boston Scientific Corporation	Phase 2	2007-03-01	The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart).
NCT00442364 ↗	Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt	Completed	BTG International Inc.	Phase 2	2007-03-01	The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart).
NCT01408732 ↗	Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia	Completed	American Rhinologic Society	Phase 1/Phase 2	2011-02-01	The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗	Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia	Completed	University of Minnesota	Phase 1/Phase 2	2011-02-01	The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗	Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia	Completed	University of Minnesota - Clinical and Translational Science Institute	Phase 1/Phase 2	2011-02-01	The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SOTRADECOL

Condition Name

Chart
Table

Condition Name for SOTRADECOL
Intervention	Trials
Epistaxis	1
Hereditary Hemorrhagic Telangiectasia	1
Varicose Veins	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SOTRADECOL
Intervention	Trials
Telangiectasia, Hereditary Hemorrhagic	1
Epistaxis	1
Varicose Veins	1
Telangiectasis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SOTRADECOL

Trials by Country

Map
Table

Trials by Country for SOTRADECOL
Location	Trials
United States	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SOTRADECOL
Location	Trials
Minnesota	1
Washington	1
Texas	1
Pennsylvania	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SOTRADECOL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SOTRADECOL
Clinical Trial Phase	Trials
Phase 2	1
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SOTRADECOL
Clinical Trial Phase	Trials
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SOTRADECOL

Sponsor Name

Chart
Table

Sponsor Name for SOTRADECOL
Sponsor	Trials
Boston Scientific Corporation	1
BTG International Inc.	1
American Rhinologic Society	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SOTRADECOL
Sponsor	Trials
Other	4
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.